Efficacy to the COVID-19 vaccine is based on both humoral (antibody) and cellular responses. Rituximab impairs B-cell response but not T-cell response to COVID-19 vaccine in auto-immune diseases @RheumNow #ACR21 8M101 Mariette X https://t.co/RoFTC6VpCt